
CQC’s new primary care framework: What GP practices should do now
CQC is retiring its single assessment framework for a primary care specific model from late 2026. Here's what's changing for GP practices, and what to do now.
Glossary
Value in use is the present value of the future cash flows expected to be derived from an asset or cash-generating unit. It reflects the economic benefit an entity expects to obtain from continuing to use the asset, including its eventual disposal.
Value in use is a measurement used in financial reporting to assess whether an asset is impaired. It represents the current worth of estimated future cash inflows and outflows arising from the continued use of an asset, discounted to reflect the time value of money and relevant risks.
In the UK, value in use is commonly applied under IAS 36 Impairment of Assets, as adopted in UK-adopted IFRS, and under Section 27 of FRS 102. It forms part of the impairment testing process, where an asset’s carrying amount is compared with its recoverable amount. Recoverable amount is the higher of fair value minus costs of disposal and value in use.
This concept ensures that assets are not carried in financial statements at amounts exceeding the economic benefits expected to be recovered from them.
Key characteristics of value in use include the following:
The calculation of value in use typically involves the following steps:
A UK manufacturing company reviews a production line for impairment due to declining demand. Management forecasts future cash flows expected from continued use of the equipment over five years, including its estimated residual value. These cash flows are discounted to present value to determine the value in use. If this amount is lower than the carrying value in the accounts, an impairment loss may be recognised.
Value in use is based on entity-specific cash flow projections from continued use. Fair value reflects the price that would be received to sell an asset in an orderly transaction between market participants.
Value in use is calculated during impairment testing, typically when there are indicators that an asset’s carrying amount may not be recoverable, or as part of annual impairment testing for certain assets such as goodwill.
Cash flows include those directly attributable to the asset’s ongoing use and its eventual disposal, based on reasonable and supportable assumptions consistent with the entity’s expectations.
Value in use uses a present value technique similar to net present value. However, it is applied specifically within financial reporting for impairment testing and follows the requirements of relevant accounting standards.
We always recommend that you seek advice from a suitably qualified adviser before taking any action. The information in this glossary entry only serves as a guide and no responsibility for loss occasioned by any person acting or refraining from action as a result of this material can be accepted by the authors or the firm.
Contact us today to find out more about how we can help you

CQC is retiring its single assessment framework for a primary care specific model from late 2026. Here's what's changing for GP practices, and what to do now.

How Price Bailey supports NRG Therapeutics with investor-led audit and governance advice as it transitions from discovery-stage research to clinical development...

Stay up-to-date with the data and stories emerging from UK valuations.

Tax Investigations Partner, Andrew Park, provides a round up of the most recent and significant contentious tax news. Read more here...